GlobalData on MSN4d
Medtronic teases positive data adaptive deep brain stimulation trialThe company published trial design and preliminary data from the adaptive DBS algorithm for personalized therapy in Parkinson ...
Medtronic (NYSE: MDT) today announced the publication of its novel approach to studying adaptive deep brain stimulation (aDBS ...
JPM24: FDA approves Medtronic’s rechargeable deep brain stimulator for Parkinson’s ... green lights near the top of this year ...
What if we could resist compulsions? These irrational behaviors, particularly common in obsessive-compulsive disorder (OCD), ...
Brian Rust of McFarland, Wisconsin, was diagnosed with an intension tremor and slated for surgery in November 2022. What ...
A team at ETH Zurich is pushing the boundaries of what can be achieved with neurostimulation and neuronal recording ...
13d
Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical ...
Abbott Laboratories will begin clinical trials for its deep-brain stimulation system for treatment-resistant depression after receiving Breakthrough Device designation from the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback